56
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy

, , , , , , & show all
Pages 371-380 | Published online: 24 Dec 2022

References

  • Meta-analysis suggests regression of left ventricular hypertrophy during antihypertensive treatment is linked to reduced risk of cardiovascular diseaseEvid Based Cardiovasc Med2004822316379885
  • BobrieGDeloncaJMoulinCA home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinationsAm J Hypertens2005181482816280286
  • CasalePNDevereuxRBMilnerMValue of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive menAnn Intern Med198610517382942070
  • ChalmersJCastaigneAMorganTLong-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patientsJ Hypertens2000183273710726720
  • ChanudetXde ChampvallinsMAntihypertensive efficacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertensionInt J Clin Pract200155233911406907
  • CiardulloAVAzzoliniLBeviniMA diagnosis of left ventricular hypertrophy on ECG is associated with a high cardiovascular risk: findings from a 40- to 69-year-old cohort in general practiceFam Pract20042163514760047
  • DahlöfBGossePGuéretPPerindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL studyJ Hypertens20052320637016208150
  • DahlöfBPennertKHanssonLReversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studiesAm J Hypertens19925951101532319
  • de LucaNMallionJMO’RourkeMFRegression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography studyAm J Hypertens200417660715323062
  • DickersonJEHingoraniADAshbyMJOptimisation of antihypertensive treatment by crossover rotation of four major classesLancet199935320081310376615
  • FranklinSSKhanSAWongNDIs pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart studyCirculation19991003546010421594
  • FrattolaAParatiGCuspidiCPrognostic value of 24-hour blood pressure variabilityJ Hypertens199311113378258679
  • GossePDubourgOGuéretPEfficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and designJ Hum Hypertens200216653912214263
  • GrandiAMBignottiMGaudioGAmbulatory blood pressure and left ventricular changes during antihypertensive treatment: Perindopril versus IsradipineJ Cardiovasc Pharmacol199526737418637188
  • HanssonLZanchettiACarruthersSGEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupLancet19983511755629635947
  • KikuyaMHozawaAOhokuboTPrognostic significance of blood pressure and heart rate variabilities: the Ohasama studyHypertension200036901611082164
  • KlingbeilAUSchneiderMMartusPA meta-analysis of the effects of treatment on left ventricular mass in essential hypertensionAm J Med200311541612867233
  • KorenMJDevereuxRBCasalePNRelation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertensionAnn Intern Med1991114345521825164
  • MallionJMChamontinBAsmarRTwenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON studyAm J Hypertens2004172455115001199
  • MatsumuraKFujiiKOnikiHRole of aldosterone in left ventricular hypertrophy in hypertensionAm J Hypertens200619131816461184
  • MillarJALeverAFBurkeVPulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension TrialJ Hypertens19991710657210466460
  • MogensenCEVibertiGHalimiSEffect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIERHypertension20034110637112654706
  • MouradJJWaeberBZannadFComparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approachJ Hypertens20042223798615614033
  • OhkuboTImaiYTsujiIPrediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in OhasamaJ Hypertens199715357649211170
  • OmboniSFogariRPalatiniPReproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect: evidence from the sample studyHypertension19983242499740606
  • ParatiGBlood pressure variability: its measurement and significance in hypertensionJ Hypertens200523SupplS1925
  • RizzoniDMuiesanMLSalvettiMThe smoothness index, but not the trough-to-peak ratio predicts changes in carotid artery wall thickness during antihypertensive treatmentJ Hypertens2001197031111330873
  • SchmiederREMartusPKlingbeilAReversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studiesJAMA19962751507138622227
  • StaessenJAThijsLFagardRPredicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial InvestigatorsJAMA19992825394610450715
  • VerdecchiaPSchillaciGBorgioniCAmbulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertensionHypertension19983298389856961